RT Journal Article
SR Electronic
T1 COVID-19 diagnosis prediction in emergency care patients: a machine learning approach
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.04.20052092
DO 10.1101/2020.04.04.20052092
A1 de Moraes Batista, André Filipe
A1 Miraglia, João Luiz
A1 Rizzi Donato, Thiago Henrique
A1 Porto Chiavegatto Filho, Alexandre Dias
YR 2020
UL http://medrxiv.org/content/early/2020/04/14/2020.04.04.20052092.abstract
AB The coronavirus disease (COVID-19) pandemic has increased the necessity of immediate clinical decisions and effective usage of healthcare resources. Currently, the most validated diagnosis test for COVID-19 (RT-PCR) is in shortage in most developing countries, which may increase infection rates and delay important preventive measures. The objective of this study was to predict the risk of positive COVID-19 diagnosis with machine learning, using as predictors only results from emergency care admission exams. We collected data from 235 adult patients from the Hospital Israelita Albert Einstein in São Paulo, Brazil, from 17 to 30 of March, 2020, of which 102 (43%) received a positive diagnosis of COVID-19 from RT-PCR tests. Five machine learning algorithms (neural networks, random forests, gradient boosting trees, logistic regression and support vector machines) were trained on a random sample of 70% of the patients, and performance was tested on new unseen data (30%). The best predictive performance was obtained by the support vector machines algorithm (AUC: 0.85; Sensitivity: 0.68; Specificity: 0.85; Brier Score: 0.16). The three most important variables for the predictive performance of the algorithm were the number of lymphocytes, leukocytes and eosinophils, respectively. In conclusion, we found that targeted decisions for receiving COVID-19 tests using only routinely-collected data is a promising new area with the use of machine learning algorithms.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe received funding from the Ministry of Health’s Institutional Development Program of the Brazilian National Health System (PROADI-SUS) "Utilização de Técnicas Avançadas de Análise de Dados (Big Data) e Inovação para Apoio ao Planejamento e Desenvolvimento de Políticas em Saúde" (NUP: 25000.028646/2018-10).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to the nature of this research, participants of this study did not agree to share publicly their individual data, so supporting data is not available.